Two biotech chief executive officers have been indicted for their roles in defrauding investors in CytoDyn, a company developing an investigational drug to treat human immunodeficiency virus, or HIV.
Special Note Regarding Forward-Looking Statements
Certain statements in this Report contain forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of. | November 14, 2022
Form S-3 CytoDyn Inc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.